Reta

Key Benefits and Research Applications:

Triple Hormonal Pathway Activation: Uniquely targets GLP-1, GIP and glucagon receptors, working through multiple metabolic pathways to support a decrease in weight and metabolic health.

Improves Appetite and Glucose Regulation: By stimulating GLP-1 and GIP receptors, it reduces hunger, increases satiety after meals, and enhances insulin secretion for better blood sugar control.

Boosts Fat Metabolism and Energy Use: Its action on the glucagon receptor helps increase energy expenditure and promotes the breakdown of stored fat.

Clinically Proven Weight Loss Effects: Clinical trials show significant reductions in body fat, waist circumference, and improvements in insulin sensitivity among individuals with obesity or type 2 diabetes.

Comprehensive Metabolic and Cardiovascular Benefits: May lower cardiovascular risk and offers a promising long-term strategy for managing obesity, metabolic syndrome and related complications.

Muscle retention: Unlike other GLP-1s, this is shown to help shift energy usage from muscle protein to stored fat, thus preserving lean mass.